TAIHO PHARMA

Exploring hidden
possibilities for
people awaiting
new medicines

We mourn the loss of those who have died from COVID-19, extend our sympathies to their loved ones, wish COVID-19 survivors rapid and permanent recoveries, and express our gratitude to medical professionals and others who support the ill.

About Taiho

Becoming a truly global specialty pharma that meets the expectations of patients worldwide.

Our Business

Taiho Pharmaceutical creates innovative, highly valuable new drugs to support patients and the advancement of medicine, seeking to contribute to smiles and health for people all around the world.

News Releases

July 01, 2021

Taiho Pharmaceutical to Provide Matching Funds to Select Crowdfunded Projects Addressing Issues in the Field of Oncology with New Taiho Smile Support Program
June 09, 2021

Taiho Pharmaceutical Adopts Carbon-Neutral Electricity at Inuyama Plant（PDF：124.7 KB）
June 09, 2021

Otsuka Group Complete Introduction of CO₂-free Electricity for All 23 Manufacturing Facilities in Japan -Contributing to a more than 40% reduction in annual CO₂ emissions in Japan-
May 27, 2021

Taiho Pharmaceutical Obtains Approval for an Additional Dosage and Administration of 5-HT₃ Receptor Antagonist Aloxi^® for Pediatric Patients in Japan（PDF：177.8 KB）
May 10, 2021

Taiho Pharmaceutical Launches New VR Content, "Virtual Patient's Journey" for Doctors, a Simulation of a Palmoplantar Pustulosis Patient's Struggles and Difficulties in Everyday Life

Information

May 13, 2021

Otsuka Holdings announces 1Q FY2021 financial results
July 12, 2018

Announcement of Support from Otsuka Holdings and Its Group Companies in the Aftermath of Severe Storms in Japan（PDF：165.9 KB）